![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1736637
¼¼°èÀÇ ½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð : À̹ÌÁö ¸ð´Þ¸®Æ¼º°, ÃÖÁ¾ »ç¿ëÀÚº°, ¿ëµµº°, Áö¿ªº°, ¿¹ÃøGlobal Cardiac Imaging Software Market Size By Imaging Modalities, By End-User, By Application, By Geographic Scope And Forecast |
½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 5¾ï 413¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2026-2032³â 8.40%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2032³â¿¡´Â 9¾ï 681¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ ½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ¿µ»ó ±â±âÀÇ ±â¼úÇâ»ó, °í·ÉÈ, ½ÉÀå¼ö¼ú Áõ°¡¿¡ ÀÇÇØ ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾î ½ÃÀå º¸°í¼´Â ÀÌ ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ºÎ¹®, µ¿Çâ, ½ÃÀå ÃËÁø ¿äÀÎ, ¾ïÁ¦ ¿äÀÎ, °æÇÕ Á¤¼¼, ½ÃÀå¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ´Â ¿äÀÎ µîÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®Çϰí ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾î ½ÃÀå °³¿ä
½ÉÇ÷°üÁúȯ(CVD)ÀÇ À¯º´·ü »ó½ÂÀº ¼¼°è ÀÔ¿øÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀÔ´Ï´Ù. WHO¿¡ µû¸£¸é CVD´Â ¼¼°è »ç¸Á¿øÀÎ 1À§ÀÌ¸ç ¸Å³â 1,800¸¸ ¸íÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ°¡´Â °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü°è ÁúȯÀÇ ºóµµ Áõ°¡ °á°ú MRI, CT ½ºÄµ, Ç÷°ü Á¶¿µ, ¹æ»ç¼º ÈÇй°Áú, ±âŸ ¹æ»ç±¤À» »ç¿ëÇÏ¿© ½ÉÀå °ü·Ã ¹®Á¦¸¦ ÆÄ¾ÇÇÏ´Â ½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾îÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ³ª¾Æ°¡ °í·ÉÀÚ Àα¸ Áõ°¡, ±â¼ú °³¼±, CT, PET µîÀÇ ½ÉÀå È»ó ¸ð´Þ¸®Æ¼ »ç¿ë Áõ°¡, ½ÉÇ÷°ü ÁúȯÀÇ ±Ùº» ¿øÀÎ Áõ°¡, ÀÌ·¯ÇÑ ¿äÀο¡ ´ëÇÑ ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ °³¹ß °èȹ µîÀÇ ¿äÀÎÀÌ ¼¼°èÀÇ ½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡ ÀÌÀÍÀ» °¡Á®´Ù ÁÙ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
°íºñ¿ëÀÇ ÁÖ¿ä ¿øÀÎÀº Ãֽбâ¼úÀÇ °í¾×ÀÇ ºñ¿ë, Áø´Ü °Ë»çÀÇ ´Ù¿ë, ¾à¸®ÇÐÀû ¹× ³»°úÀû Ä¡·á¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù. ¹Ì±¹¿¡¼´Â È»ó Áø´Ü ºñ¿ëÀÌ ¸Å³â 1,000¾ï ´Þ·¯¸¦ ³Ñ°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü È»ó Áø´Ü(CVI)Àº È»ó Áø´ÜÀÇ ÃÑ ºÎ´ãÀÇ 29%¸¦ Â÷ÁöÇϰí, Àü¼¼°è¿¡¼ ¸Å³â ½Ç½ÃµÇ°í ÀÖ´Â ¼ö½Ê¾ï°ÇÀÇ È»ó Áø´Ü °Ë»çÀÇ Àû¾îµµ 3ºÐÀÇ 1À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÀÌ ¹è°æ¿¡´Â, ÇÁ·ÎÇÁ¶óÀÌ¾î ¿¡Å͸®ÇÑ ¼ÒÇÁÆ®¿þ¾î Á¦Ç°À̳ª, ´Ù¸¥ ¼ÒÇÁÆ®¿þ¾î³ª Çϵå¿þ¾îÀÇ ÇÁ·Î¹ÙÀÌ´õ¿ÍÀÇ »óÈ£ ¿î¿ë¼ºÀÌ Â¥³Ö¾îÁ® ÀÖ´Â °ÍÀÌ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ °ø±ÞÀÚ °£¿¡ ÅëÀϼºÀÌ ¾ø½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ´Ù¾çÇÑ °ø±ÞÀÚ°¡ Á¦Á¶ÇÑ ±â±â¿¡¼ µ¥ÀÌÅ͸¦ ÃëµæÇÒ °¡´É¼ºÀÌ ÀÖ¾î ´Ù½Ã¼³, Áý´Ü ±â¹Ý ¿¬±¸¸¦ ½Ç½ÃÇÏ´Â °ÍÀº ¾î·Æ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ¼¼°è ½ÉÀå À̹ÌÁö ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀº µÐ鵃 °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.
The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.
The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Cardiac Imaging Software Market Overview
The rising prevalence of cardiovascular diseases (CVD) is one of the primary reasons for hospitalization worldwide. According to WHO, CVDs are the leading cause of mortality worldwide, claiming an estimated 18 million lives each year. As a result of the increased frequency of cardiovascular disorders, there is a greater need for cardiac imaging software to identify heart-related issues using MRI, CT scan, angiography, radioactive chemicals, and other types of radiant light. Furthermore, factors such as an increase in the older population, technological improvements, and increased use of cardiac imaging modalities such as CT, PET, and others, a Rise in underlying causes of cardiovascular disease, and market participants' development plans of these factors are projected to benefit the worldwide Cardiac Imaging Software Market.
The high cost is mostly due to the high expense of contemporary technology, the extensive use of diagnostic tests, and pharmacological and medical therapies. In the United States, imaging expenses surpass USD 100 billion each year. Cardiovascular imaging (CVI) accounts for 29 percent of the total imaging burden and at least one-third of the several billion medical imaging exams conducted worldwide each year. Furthermore, this was ascribed in part to proprietary software products and their built-in interoperability with other software and hardware providers. Furthermore, there is a lack of uniformity across providers. This makes multi-site, population-based research challenging to conduct, as data may be acquired from gear produced by various suppliers. This is projected to slow the global Cardiac Imaging Software Market's growth.
The Global Cardiac Imaging Software Market is Segmented on the basis of Imaging Modalities, End-User, Application, and Geography.
Based on Imaging Modalities, the market is segmented into Computed Tomography, Magnetic Resonance, Ultrasound Imaging, X-Ray Imaging, and Combined Modalities. The computed tomography sector is predicted to increase at a healthy rate over the projection period because it is more efficient than conventional X-rays at delivering doses of cancer-damaging radiation.
Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. The market has seen a dramatic surge in the number of patients suffering from cardiovascular illnesses such as coronary heart disease, heart attacks, strokes, congenital heart disease, and others during the previous few years. The number of hospitals worldwide is steadily rising as the number of patients increases. By end-user, hospitals and clinics dominate the worldwide Cardiac Imaging Software Market. This share is mostly due to an increase in the number of individuals being monitored for a heart condition.
Based on Application, the market is segmented into Diagnostic Imaging, Image Guided, and Patient Monitoring.
The "Global Cardiac Imaging Software Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Shimadzu Corporation, Koninklijke Philips NV, Siemens AG, Canon Inc., Agfa-Gevaert Group, General Electric, Circle Cardiovascular, Fujifilm Holdings Corporation, Symphony Innovation, LLC, and Pie Medical Imaging.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.